University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
035 Continuation study
An open-label treatment-option protocol of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma systemic anaplastic large cell lymphoma or CD30-positive cutaneous T-cell lymphomaView Trial
NMR metabolomics on exhaled breath condensate as a biomarker of lung involvement in rheumatoid arthritisView Trial
GO40241: A PHASE III DOUBLE-BLINDED MULTICENTER RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT TREATMENT WITH ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE II IIIA OR SELECT IIIB NON-SMALL CELL LUNG CANCERView Trial
Mesothelioma and Radical Surgery 2: a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaView Trial
Person Centred Planning for Children Young People and Families with life limiting or life threatening illness: A scoping exercise exploring its use in practice within three care settingsView Trial
Multi-drug genetic marker-directed non-comparative multi-arm Phase II trial in Non-Small Cell Lung CancerView Trial
A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced CancersView Trial
Safety and Tolerability of AGI-134
A phase I/IIa multicentre open label study designed to evaluate the safety and tolerability of AGI-134 as monotherapy and in combination with pembrolizumab in unresectable metastatic solid tumoursView Trial
A Randomized Double-Blind Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)View Trial
Body fat distribution and diabetes risk: the role of adipose tissue oxygen metabolismView Trial